Genotype-phenotype correlations in Down syndrome identified by array CGH in 30 cases of partial trisomy and partial monosomy chromosome 21
about
Alzheimer's disease amyloid-beta links lens and brain pathology in Down syndromeConcise review: new paradigms for Down syndrome research using induced pluripotent stem cells: tackling complex human genetic diseaseDown syndrome: searching for the genetic culpritsDYRK1A, a Dosage-Sensitive Gene Involved in Neurodevelopmental Disorders, Is a Target for Drug Development in Down SyndromeConcise Review: Methods and Cell Types Used to Generate Down Syndrome Induced Pluripotent Stem CellsMouse models of Down syndrome as a tool to unravel the causes of mental disabilitiesModeling partial monosomy for human chromosome 21q11.2-q21.1 reveals haploinsufficient genes influencing behavior and fat depositionAneuploidy: a common and early evidence-based biomarker for carcinogens and reproductive toxicantsDown Syndrome: Current Status, Challenges and Future PerspectivesTrisomy for synaptojanin1 in Down syndrome is functionally linked to the enlargement of early endosomesDosage of the Abcg1-U2af1 region modifies locomotor and cognitive deficits observed in the Tc1 mouse model of Down syndromeDeficiencies in the region syntenic to human 21q22.3 cause cognitive deficits in mice.Congenital heart disease protein 5 associates with CASZ1 to maintain myocardial tissue integrity.Discovery of novel serum biomarkers for prenatal Down syndrome screening by integrative data mining.Distinctive Phenotypic Abnormalities Associated with Submicroscopic 21q22 Deletion Including DYRK1A.Array CGH in human leukemia: from somatics to genetics.Abrogation of RUNX1 gene expression in de novo myelodysplastic syndrome with t(4;21)(q21;q22).Opposite chromosome constitutions due to a familial translocation t(1;21)(q43;q22) in 2 cousins with development delay and congenital anomalies: A case report.Engineered chromosome-based genetic mapping establishes a 3.7 Mb critical genomic region for Down syndrome-associated heart defects in miceMolecular basis of pharmacotherapies for cognition in Down syndromeCognition and hippocampal plasticity in the mouse is altered by monosomy of a genomic region implicated in Down syndromeMeta-analysis of heterogeneous Down Syndrome data reveals consistent genome-wide dosage effects related to neurological processesFunctional transcriptome analysis of the postnatal brain of the Ts1Cje mouse model for Down syndrome reveals global disruption of interferon-related molecular networksConflicting results of prenatal FISH with different probes for Down's Syndrome critical regions associated with mosaicism for a de novo del(21)(q22) characterised by molecular karyotyping: Case reportThe complex SNP and CNV genetic architecture of the increased risk of congenital heart defects in Down syndrome.Phenotypic consequences of aneuploidy in Arabidopsis thaliana.Global DNA hypermethylation in down syndrome placentaDown syndrome--recent progress and future prospects.Mechanisms of x chromosome dosage compensation.Identification of a DNA methylation signature in blood cells from persons with Down Syndrome.Opposite phenotypes of muscle strength and locomotor function in mouse models of partial trisomy and monosomy 21 for the proximal Hspa13-App region.Predictive performance of a seven-plex antibody array in prenatal screening for Down Syndrome.The chromatin-binding protein HMGN1 regulates the expression of methyl CpG-binding protein 2 (MECP2) and affects the behavior of miceTrisomic and allelic differences influence phenotypic variability during development of Down syndrome mice.Genetic analysis of Down syndrome-associated heart defects in mice.Deletion of the App-Runx1 region in mice models human partial monosomy 21."Down syndrome: an insight of the disease"Copy Number Variants Associated with 14 Cases of Self-Injurious BehaviorDouble deletion of a chromosome 21 inserted in a chromosome 22 in an azoospermic patient.Systematic Tracking of Disrupted Modules Identifies Altered Pathways Associated with Congenital Heart Defects in Down Syndrome.
P2860
Q21136371-E7A2273E-3450-4A35-A5C5-9F07F7F1AFD9Q22241147-E382E464-2EBA-4B3F-8C36-CE4BF6349256Q22241596-716BEBD3-EA6B-4337-8C7A-4BBBB0FAB855Q26745413-5EFF9AF4-BAE9-48B0-A8F9-8555C4BB4AB8Q26799570-D28A8BA3-ABBB-428E-A9E4-3AC83792C985Q26863005-BA248080-D4A5-4832-BAFB-DC58C7B6EA5DQ27310353-534E7E9C-3E80-461C-AC9E-37B20F96EBAFQ28078495-0A6309C8-221D-46BF-8C1F-528D3ADBB6C8Q28079334-72CCEC80-888F-4D44-9D1A-2851C4C53B13Q28118988-CE357725-039E-4164-93E2-2771E5DDB534Q28543589-9C946B41-96DD-4F17-B12A-FFA2CD79E54EQ30497935-B2D8910C-E518-47C0-8A83-46178AD4D0F9Q30592648-6F44042A-A084-4DCE-8A42-A3FA1732E4C7Q30943859-7AD401EF-8886-4855-BD84-FA00AE651BCAQ33392551-0C1D87FF-F977-43E7-99BD-65B7598D94D1Q33397024-13B46B93-0C4B-4D3B-B714-01E662F82C31Q33398370-F6571703-984D-4774-B27E-2C8647880F8CQ33606086-C7BAD11D-2581-4FAE-B0B7-3FBA41B6B377Q33624012-04DC17B6-6B05-41D7-97CF-55323C537E50Q33625613-AB52C28A-E08B-403F-8381-5C070EC1F43CQ33895060-406EA8C5-8908-4518-A799-094B400937EBQ33898516-9B67314D-308A-4CE5-A4CA-E186A485B685Q34012056-10241390-6FDF-4400-AD9B-7D0C74D8C8E0Q34148812-E26114ED-22C8-43D9-B7C3-2F32526133B2Q34352054-9237F7F3-E9E7-48B3-BE13-E1E7515A4DCAQ34386902-ED8CF3A2-F3B5-42E3-AA7A-A3191E125802Q34765333-FEFD70EF-F0DB-42D1-B41F-013DF83D563FQ34964947-2413C81A-A2B4-4CD9-8826-ECC37DE62A78Q35002469-F8B66E86-3E8A-4DF5-ADCB-8F7D7F5382A9Q35177595-283AC2BF-7CE3-43D6-862D-49946EAB487BQ35214206-4D03725D-C176-415E-BCA5-7962389F3A12Q35578801-0E4C1B3F-166F-4485-95EC-334131342428Q35604954-82BE66D9-1775-41A4-8233-B2D1F0BC8604Q35620481-93C02BA8-BA38-438C-9D35-2E2C9B6FAE65Q35669274-8AAE443D-AEDD-48D6-87A9-6F9421AEE22FQ35687108-937D08FC-D86D-4AAD-A8F5-E41E1A16D614Q35730155-A51C1A71-F9CA-4793-ADF7-491E02716F46Q35942634-D3EB7DDF-2019-4896-8E7A-F0F09454636BQ36072374-B4E46C7A-3E1B-41EC-B4FB-868F0DF638DCQ36255505-17EBE65B-B463-49AA-A997-E38ED234B6BC
P2860
Genotype-phenotype correlations in Down syndrome identified by array CGH in 30 cases of partial trisomy and partial monosomy chromosome 21
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Genotype-phenotype correlation ...... partial monosomy chromosome 21
@ast
Genotype-phenotype correlation ...... partial monosomy chromosome 21
@en
Genotype-phenotype correlation ...... partial monosomy chromosome 21
@nl
type
label
Genotype-phenotype correlation ...... partial monosomy chromosome 21
@ast
Genotype-phenotype correlation ...... partial monosomy chromosome 21
@en
Genotype-phenotype correlation ...... partial monosomy chromosome 21
@nl
prefLabel
Genotype-phenotype correlation ...... partial monosomy chromosome 21
@ast
Genotype-phenotype correlation ...... partial monosomy chromosome 21
@en
Genotype-phenotype correlation ...... partial monosomy chromosome 21
@nl
P2093
P2860
P50
P356
P1476
Genotype-phenotype correlation ...... partial monosomy chromosome 21
@en
P2093
Albert Schinzel
Anna Pelet
Armand Bottani
Corinne Gehrig
Emilie Aït Yahya-Graison
Frédérique Béna
Gipsy Lopez
James Lespinasse
Jean M Delabar
Judy C Franklin
P2860
P2888
P304
P356
10.1038/EJHG.2008.214
P50
P577
2008-11-12T00:00:00Z
P5875
P6179
1015754866